Literature DB >> 33220727

Ct values and infectivity of SARS-CoV-2 on surfaces.

Günter Kampf1, Sebastian Lemmen2, Miranda Suchomel3.   

Abstract

Entities:  

Year:  2020        PMID: 33220727      PMCID: PMC7832744          DOI: 10.1016/S1473-3099(20)30883-5

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
Akiko Iwasaki raises the important question of whether a person with a positive PCR test result for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is automatically infectious or infectious only if the cycle threshold (Ct) is below a certain value (eg, <35). The same question should be asked for other potential sources of viral spread, such as inanimate surfaces. Through a search of MEDLINE up to Oct 6, 2020, we identified six studies with original data on surface contamination with SARS-CoV-2 (RNA and infectious virus; appendix). Viral RNA was found in the surroundings of confirmed COVID-19 cases in 1·0–52·7% of samples. In five studies, infectious SARS-CoV-2 was not detected on any surface. In one study, infectious virus was detected in 9·2% of samples, which was mainly explained by a single patient with persistent cough and frequent sputum spitting during sampling (appendix). The findings are consistent with laboratory data showing for SARS-CoV-2 that Ct values of 29·3 (steel surface) or 29·5 (plastic surface) correlate with the detection of culturable virus, whereas Ct values of 32·5 (steel surface) or 32·7 (plastic surface) correlate with the detection of non-culturable virus. SARS-CoV-2 RNA can be found on inanimate surfaces up to 28 days after discharge of patients with COVID-19, which further limits the relevance of RNA detection on surfaces. A Ct value higher than 33 obtained from a surface sample probably has no epidemiological relevance. In public settings, contamination with infectious virus is even less likely than in hospitals. Viral contamination can occur only in the unlikely event a SARS-CoV-2 carrier comes near to a surface. The potential viral source is not permanently present next to the surface, probably has no symptoms, and may wear a face mask, resulting in a low probability of viral spread. In workplaces it was found that only five (0·6%) of 841 tests among employees were positive for SARS-CoV-2 RNA over a period of 2 weeks, with Ct values between 33 and 36. Among 5500 surface samples, only 44 (0·8%) were positive, with Ct values between 34 and 38, indicating that viral loads were indeed very low on surfaces in close and permanent proximity to viral shedders. A simple binary approach to the interpretation of PCR results will result in the possible segregation of large numbers of people who are not infectious and, hence, not a threat to public health. It will probably also result in regular disinfection of surfaces, leading to a reduction in the diversity of the microbiome and an increase in the diversity of resistance genes. Permanent exposure of bacteria to subinhibitory concentrations of some biocidal agents used for surface disinfection can cause a strong adaptive cellular response, resulting in stable tolerance to the biocidal agents and, in some cases, in new antibiotic resistance. We propose to routinely clean public surfaces, and to consider surface disinfection only when there is evidence that a surface is contaminated with a sufficient amount of infectious virus and is likely to contribute to viral transmission that cannot be controlled by other measures, such as surface cleaning or handwashing.
  15 in total

1.  Environmental Detection of SARS-CoV-2 Virus RNA in Health Facilities in Brazil and a Systematic Review on Contamination Sources.

Authors:  Vania Aparecida Vicente; Bruno Paulo Rodrigues Lustosa; Maria Eduarda Grisolia; Caroline Pavini Beato; Eduardo Balsanelli; Viviane de Souza Gubert Fruet; Meri Bordignon Nogueira; Sonia Maria Raboni; Katherine Athayde Teixeira Carvalho; Izadora Cervelin Flôr; Morgana Ferreira Voidaleski; Ramiro Gonçalves Etchepare; Jacques F Meis; Vanete Thomaz Soccol; Emanuel Maltempi Souza
Journal:  Int J Environ Res Public Health       Date:  2021-04-06       Impact factor: 3.390

2.  Diagnostic performance of rapid antigen tests (RATs) for SARS-CoV-2 and their efficacy in monitoring the infectiousness of COVID-19 patients.

Authors:  John G Routsias; Maria Mavrouli; Panagiota Tsoplou; Kyriaki Dioikitopoulou; Athanasios Tsakris
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379

Review 3.  Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication.

Authors:  Zheng Yao Low; Ashley Jia Wen Yip; Sunil K Lal
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-10-20       Impact factor: 5.187

4.  Accuracy of anterior nasal swab rapid antigen tests compared with RT-PCR for massive SARS-CoV-2 screening in low prevalence population.

Authors:  Kathrine Kronberg Jakobsen; Jakob Schmidt Jensen; Tobias Todsen; Nikolai Kirkby; Freddy Lippert; Anne-Marie Vangsted; Mads Klokker; Christian von Buchwald
Journal:  APMIS       Date:  2021-12-06       Impact factor: 3.428

5.  Sensitivity and specificity of two WHO approved SARS-CoV2 antigen assays in detecting patients with SARS-CoV2 infection.

Authors:  Chandima Jeewandara; Dinuka Guruge; Pradeep Darshana Pushpakumara; Deshan Madhusanka; Tibutius Thanesh Jayadas; Indika Prasad Chaturanga; Inoka Sepali Aberathna; Saubhagya Danasekara; Thilagaraj Pathmanathan; Deshni Jayathilaka; Gayasha Somathilaka; Heshan Kuruppu; Laksiri Gomes; Vitjith Gunasekara; Ruwan Wijayamuni; Graham S Ogg; Gathsaurie Neelika Malavige
Journal:  BMC Infect Dis       Date:  2022-03-22       Impact factor: 3.090

Review 6.  Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms.

Authors:  Mahender Aileni; Gulab Khan Rohela; Phanikanth Jogam; Shakuntala Soujanya; Baohong Zhang
Journal:  Cells       Date:  2022-03-31       Impact factor: 6.600

7.  Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon.

Authors:  Ali A Samaha; Hussein Mouawia; Mirna Fawaz; Hamad Hassan; Ali Salami; Ali Al Bazzal; Hamid Bou Saab; Mohamed Al-Wakeel; Ahmad Alsaabi; Mohamad Chouman; Mahmoud Al Moussawi; Hassan Ayoub; Ali Raad; Ola Hajjeh; Ali H Eid; Houssam Raad
Journal:  Viruses       Date:  2021-05-26       Impact factor: 5.048

Review 8.  COVID-19 in Germany and China: mitigation versus elimination strategy.

Authors:  Guangyu Lu; Oliver Razum; Albrecht Jahn; Yuying Zhang; Brett Sutton; Devi Sridhar; Koya Ariyoshi; Lorenz von Seidlein; Olaf Müller
Journal:  Glob Health Action       Date:  2021-01-01       Impact factor: 2.640

9.  Detection and Genome Sequencing of SARS-CoV-2 in a Domestic Cat with Respiratory Signs in Switzerland.

Authors:  Julia Klaus; Marina L Meli; Barbara Willi; Sarah Nadeau; Christian Beisel; Tanja Stadler; Herman Egberink; Shan Zhao; Hans Lutz; Barbara Riond; Nina Rösinger; Hanspeter Stalder; Sandra Renzullo; Regina Hofmann-Lehmann
Journal:  Viruses       Date:  2021-03-17       Impact factor: 5.048

Review 10.  [Disinfectants during the COVID-19 pandemic: a challenge].

Authors:  Maren Eggers; Anna Baumann; Nils Lilienthal; Eike Steinmann; Jochen Steinmann; Nils-Olaf Hübner; Holger F Rabenau; Viola Weinheimer; Ingeborg Schwebke
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-12-08       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.